Abstract
Background: We used a combination of genetic subtraction, silicon DNA micro-array analysis, and quantitative PCR to identify tissue-and tumor-specific genes as diagnostic targets for breast cancer.
Methods and Results: From a large number of candidate antigens, several specific subsets of genes were identified that showed concordant and complementary expression profiles. Whereas transcriptional profiling of mammaglobin resulted in the detection of 70% of tumors in a panel of 46 primary and metastatic breast cancers, the inclusion of three additional markers resulted in detection of all 46 specimens. Immunomagnetic epithelial cell enrichment of circulating tumor cells from the peripheral blood of patients with metastatic breast cancer, coupled with RT-PCR-based amplification of breast tumor—specific transcripts, resulted in the detection of anchorage-independent tumor cells in the majority of patients with breast cancer with known metastatic disease.
Conclusion: Complementation of mammaglobin with three additional genes in RT-PCR increases the detection of breast cancers in tissue and circulating tumor cells.
Article PDF
Similar content being viewed by others
References
Donegan WL, Spratt JS: Cancer of the breast, 4th ed. Saunders, Philadelphia, 1995
Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA, Ullrich A: Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res 1990;50:1550–1558
Baselga J, Norton L, Albanell J, Kim YM, Mendolsohn J: Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu over-expressing human breast cancer xenografts. Cancer Res 1998;58:2825–2831
Pegram MD, Lipton A, Hayes DF, et al.: Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-pl85HER2/neu monoclonal antibody plus cisplatin in patients with HER2/ neu overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 1998; 16:2659–2671
Drebin JA, Link VC, Greene MI: Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. Oncogene 1988;2:387–394
Disis ML, Shiota FM, Cheever MA: Human HER-2/neu protein immunization circumvents tolerance to rat neu: A vaccine strategy for “self” tumour antigens. Immunology 1998;93:192–199
Disis ML, Cheever MA: HER-2/neu oncogenic protein: Issues in vaccine development. Crit Rev Immunol 1998;18:37–45
Disis ML, Grabstein KH, Sleath PR, Cheever MA: Generation of immunity to the HER-2/neu oncogeneic protein in patients with breast and ovarian cancer using a peptide-based vaccine. Clin Cancer Res 1999;5:1289–1297
Watson MA, Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996;56:860–865
Watson MA, Dintzis S, Darrow CM, et al.: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 1999;59:3028–3031
Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP: Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 1998; 16:817–824
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. Histopathology 1991;19:403–410
Porter-Jordan K, Lippman ME: Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 1994;8:73–100
Leygue E, Snell L, Dotzlaw H, et al.: Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol 1999;189:28–33
Min JC, Tafra L, Verbanac KM: Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 1998;58:4581–4584
Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D: Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 1999;17:2015–2019
Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science 1993;257:967–971
Mou E, Miller H, Li J, Wand E, Chalifour L: Improvements to the differential display method for gene analysis. Biochem Biophy Res Commun 1994; 199:564–569
Hara T, Harada N, Mitsui H, Miura T, Ishizaka T, Miyajima A: Characterization of cell phenotype by a novel cDNA library subtraction system: Expression of CD8 alpha in a mast cell derived interleukin-4 dependent cell line. Blood 1994;84:189–199
Diatchenko L, Lau Y-FC, Campbell AP, et al.: Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 1996;93:6025–6030
Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ: Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 1999;27:1517–1523
Shalon D, Smith SJ, Brown PO: A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res 1996,6:639–645
Holland PM, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276–7280
Schneeberger C, Spieser P, Kury F, Zeillinger R: Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain. PCR Methods Appl 1995;4:234–238
Momburg F, Moldenhauer G, Hammerling GJ, Moller P: Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987;41:2883–2891
Naume B, Borgen E, Beiske K, et al.: Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hemother 1997;6:103–113
Naume B, Borgen E, Nesland JM, et al.: Increased sensitivity for detection of micrometastases in bone marrow/peripheral blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 1998;78:556–560
Martin VM, Siewert C, Scharl A, et al.: Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998;26:252–264
Hildebrandt M, Mapara MY, Korner IJ, Bargou RC, Moldenhauer G, Dorken B: Reverse transcriptasepolymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: A sensitive method for monitoring purging efficiency. Exp Hematol 1997;25:57–65
Eaton MC, Hardingham JE, Kotasek D, Dobrovic A: Immunobead RT-PCR: A sensitive method for the detection of circulating tumor cells. Biotechniques 1997;22:100–105
Brandt B, Griwatz C, Heidi S, Assmann G, Zanker KS: Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR. Clin Exp Metastases 1996;14:399–408
Hedblom E, Kirkness EF: A novel class of GABAA receptor subunit in tissues of the reproductive system. J Biol Chem 1997;272:15346–15350
Houghton RL, Frudakis A, Schmidt C, et al.: Real time PCR and microarray analysis of breast cancer genes identified using differential display techniques. Cancer Res 1999;40:32–33 (abstr 217)
Jiang J, Xu J, Houghton RL, Silva S, Reed SG: Discovery of breast cancer antigens using subtracted cDNA libraries and cDNA microarrays. Proc Am Assoc Cancer Res 1999;40:32 (abstr 216)
Xu J, Stolk J, Silva S, Houghton RL, Reed SG: Identification of differentially expressed genes in human breast tumor using subtraction and microarray. Proc Am Assoc Cancer Res 1999;40:319 (abstr 2115)
Molesh DA, Dillon DC, Schmidt J, et al.: Real time PCR analysis of breast cancer genes identified using cDNA library subtraction and differential display methods. Proc Am Assoc Cancer Res 2000;41:681 (abstr 4330)
Wick MR, Ockner DM, Mills SE, Ritter JH, Swanson PE: Homologous carcinomas of the breasts, skin and salivary glands. A histologic and histochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol 1998;109:75–84
Pfeifer JD, Barr RJ, Wick MR: Ectopic breast tissue and breast-like sweat gland metaplasias: An overlapping spectrum of lesions. J Cutan Pathol 1999; 26:190–196
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houghton, R.L., Dillon, D.C., Molesh, D.A. et al. Transcriptional Complementarity in Breast Cancer: Application to Detection of Circulating Tumor Cells. Molecular Diagnosis 6, 79–91 (2001). https://doi.org/10.1007/BF03262038
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03262038